RILYG Fundamental Analysis - B RILEY FINANCIAL INC - RILY 5 12/31/26

Fundamental Rating

Overall RILYG gets a fundamental rating of 2 out of 10. We evaluated RILYG against 235 industry peers in the Capital Markets industry. Both the profitability and financial health of RILYG have multiple concerns. RILYG does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year RILYG has reported negative net income.

RILYG had a negative operating cash flow in the past year.

The reported net income has been mixed in the past 5 years: RILYG reported negative net income in multiple years.

Each year in the past 5 years RILYG had a positive operating cash flow.

1.2 Ratios

RILYG has a Return On Assets of -10.36%. This is amonst the worse of the industry: RILYG underperforms 83.40% of its industry peers.

		Industry Rank	Sector Rank
ROA	-10.36%
ROE	N/A
ROIC	N/A

ROA(3y)-15.94%

ROA(5y)-6.57%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 54.73%, RILYG is in the better half of the industry, outperforming 64.26% of the companies in the same industry.

RILYG's Gross Margin has declined in the last couple of years.

RILYG does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	54.73%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-29.32%

GM growth 5Y-17.83%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

RILYG has more shares outstanding than it did 1 year ago.

RILYG has more shares outstanding than it did 5 years ago.

Compared to 1 year ago, RILYG has a worse debt to assets ratio.

2.2 Solvency

RILYG has an Altman-Z score of -0.66. This is a bad value and indicates that RILYG is not financially healthy and even has some risk of bankruptcy.

With a Altman-Z score value of -0.66, RILYG is not doing good in the industry: 81.70% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Altman-Z	-0.66

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

RILYG has a Current Ratio of 1.42. This is a normal value and indicates that RILYG is financially healthy and should not expect problems in meeting its short term obligations.

RILYG has a better Current ratio (1.42) than 65.96% of its industry peers.

A Quick Ratio of 1.27 indicates that RILYG should not have too much problems paying its short term obligations.

The Quick ratio of RILYG (1.27) is comparable to the rest of the industry.

		Industry Rank	Sector Rank
Current Ratio	1.42
Quick Ratio	1.27

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

RILYG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 75.67%, which is quite impressive.

The Revenue for RILYG has decreased by -23.39% in the past year. This is quite bad

RILYG shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.49% yearly.

EPS 1Y (TTM)75.67%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%131.35%

Revenue 1Y (TTM)-23.39%

Revenue growth 3Y-30.61%

Revenue growth 5Y-2.49%

Sales Q2Q%3315.26%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

RILYG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 19.09%, RILYG is a good candidate for dividend investing.

RILYG's Dividend Yield is rather good when compared to the industry average which is at 6.65. RILYG pays more dividend than 95.32% of the companies in the same industry.

RILYG's Dividend Yield is rather good when compared to the S&P500 average which is at 2.00.

		Industry Rank	Sector Rank
Dividend Yield	19.09%

5.2 History

The dividend of RILYG decreases each year by -2.19%.

RILYG has been paying a dividend for over 5 years, so it has already some track record.

The dividend of RILYG decreased in the last 3 years.

Dividend Growth(5Y)-2.19%

Div Incr Years0

Div Non Decr Years2

5.3 Sustainability

RILYG has negative earnings and hence a negative payout ratio. The dividend may be in danger.

DP-2.58%

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

B RILEY FINANCIAL INC - RILY 5 12/31/26

NASDAQ:RILYG (12/29/2025, 10:17:23 AM)

19.69

+0.11 (+0.56%)

Chartmill FA Rating

GICS SectorFinancials

GICS IndustryGroupFinancial Services

GICS IndustryCapital Markets

Earnings (Last)N/A N/A

Earnings (Next)01-12 2026-01-12

Inst Owners21.87%

Inst Owner ChangeN/A

Ins Owners30.05%

Ins Owner ChangeN/A

Market Cap602.51M

Revenue(TTM)734.24M

Net Income(TTM)-160.07M

Analysts0

Price TargetN/A

Short Float %0.08%

Short Ratio1.28

Dividend

		Industry Rank	Sector Rank
Dividend Yield	19.09%

Yearly Dividend1.38

Dividend Growth(5Y)-2.19%

DP-2.58%

Div Incr Years0

Div Non Decr Years2

Ex-Date01-15 2026-01-15 (0.3125)

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.82
P/FCF	N/A
P/OCF	N/A
P/B	N/A
P/tB	N/A
EV/EBITDA	N/A

EPS(TTM)-5.26

EYN/A

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)-0.66

FCFYN/A

OCF(TTM)-0.28

OCFYN/A

SpS23.99

BVpS-11.49

TBVpS-28.62

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-10.36%
ROE	N/A
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	54.73%
FCFM	N/A

ROA(3y)-15.94%

ROA(5y)-6.57%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-29.32%

GM growth 5Y-17.83%

F-Score5

Asset Turnover0.48

Health

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	27.93%
Cap/Sales	1.57%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.42
Quick Ratio	1.27
Altman-Z	-0.66

F-Score5

WACCN/A

ROIC/WACCN/A

Cap/Depr(3y)14.29%

Cap/Depr(5y)11.22%

Cap/Sales(3y)0.81%

Cap/Sales(5y)0.54%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)75.67%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%131.35%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-23.39%

Revenue growth 3Y-30.61%

Revenue growth 5Y-2.49%

Sales Q2Q%3315.26%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y21.06%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-116.04%

FCF growth 3Y72.02%

FCF growth 5YN/A

OCF growth 1Y-106.48%

OCF growth 3Y73.01%

OCF growth 5YN/A

B RILEY FINANCIAL INC - RILY 5 12/31/26 / RILYG FAQ

What is the fundamental rating for RILYG stock?

ChartMill assigns a fundamental rating of 2 / 10 to RILYG.

What is the valuation status of B RILEY FINANCIAL INC - RILY 5 12/31/26 (RILYG) stock?

ChartMill assigns a valuation rating of 0 / 10 to B RILEY FINANCIAL INC - RILY 5 12/31/26 (RILYG). This can be considered as Overvalued.

What is the profitability of RILYG stock?

B RILEY FINANCIAL INC - RILY 5 12/31/26 (RILYG) has a profitability rating of 2 / 10.

What is the financial health of B RILEY FINANCIAL INC - RILY 5 12/31/26 (RILYG) stock?

The financial health rating of B RILEY FINANCIAL INC - RILY 5 12/31/26 (RILYG) is 2 / 10.

B RILEY FINANCIAL INC - RILY 5 12/31/26 (RILYG) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

5.2 History

5.3 Sustainability

More info and screens

B RILEY FINANCIAL INC - RILY 5 12/31/26 / RILYG FAQ

What is the fundamental rating for RILYG stock?

What is the valuation status of B RILEY FINANCIAL INC - RILY 5 12/31/26 (RILYG) stock?

What is the profitability of RILYG stock?

What is the financial health of B RILEY FINANCIAL INC - RILY 5 12/31/26 (RILYG) stock?